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Introduction: Radiation therapy (RT) is effective treatment for curing and palliating cancer, yet concern exists that
not all Canadians for whom RT is indicated receive it. Many factors may contribute to suboptimal use of RT. A
review of recent Canadian literature was undertaken to identify such barriers.
Methods: MEDLINE, CINAHL, and EMBase databases were used to search keywords relating to barriers to accessing
or utilizing RT in Canada. Collected abstracts were reviewed independently. Barriers identified in relevant articles
were categorized as relating to the health systems, patient socio-demographic, patient factors, or provider factors
contexts and thematic analysis performed for each context.
Results: 535 unique abstracts were collected. 75 met inclusion criteria. 46 (61.3%) addressed multiple themes. The
most cited barriers to accessing RT when indicated were patient age (n = 26, 34.7%), distance to treatment centre
(n = 23, 30.7%), wait times (n = 22, 29.3%), and lack of physician understanding about the use of RT (n = 16, 21.6%).
Conclusions: Barriers to RT are reported in many areas. The role of provider factors and the lack of attention to
patient fears and mistrust as potential barriers were unexpected findings demanding further attention. Solutions
should be sought to overcome identified barriers facilitating more effective cancer care for Canadians.
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Radiation therapy (RT) is a highly effective treatment
modality to cure and palliate cancer. As noted by the
Chair of the Canadian Association of Radiation Oncolo-
gy’s Manpower Committee, 100,000 courses of RT were
administered in Canada in 2010, at more than 35 radia-
tion treatment facilities, and yet there is concern that
not all Canadians for whom RT might be indicated are
receiving it.
In a 2009 Cancer System Quality Index (CSQI) report,
Ontario adopted a benchmark for RT utilization, based
on the estimate that 48% of those receiving a cancer
diagnosis would require RT at some point in the course
of their disease [1,2]. Studies in other countries have
made similar estimates [3,4]. Current Canadian utiliza-
tion rates fall below this benchmark, as can be suggested* Correspondence: caitlin.gillan@rmp.uhn.on.ca
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reproduction in any medium, provided the orby the fact that 32.8% of those diagnosed with cancer in
Ontario, and 31.0% nationally, are receiving a course of
RT within two years of diagnosis [5]. A number of fac-
tors may be contributing to suboptimal RT utilization
rates, from those attributable to the health care system
[6-8] to those relating directly to the patient and the
provider [9-14].
In order to better understand barriers to access and
use of this important cancer treatment modality, a review
of the recent Canadian literature was undertaken.Methods
Definitions
Guiding definitions of both “barrier” and “access” were
established. The definition of access was modified from
Turnock [15], and was equated with a consultation for
RT. To ensure a comprehensive assessment of factors
affecting access, the definition of “barrier” was broadly
determined to be anything potentially impeding access.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Conducted within the
Canadian context
• Focuses only on clinical practice




• Discusses cancer care more broadly,
without specific reference to radiation
therapy
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The MEDLINE, CINAHL, and EMBase databases were
used to search keywords relating to barriers to accessing
or utilizing RT in Canada. A list of keywords was created
by investigators in collaboration with a medical librarian,
and was informed by a previous preliminary search con-
ducted by investigators. The initial search was conducted
within the timeframe of 1980 through July 2011.
Efforts were made to limit the search to articles re-
porting on work conducted in the Canadian context to
ensure that the results were relevant to the Canadian
healthcare system and population.
Initial categorization
Citations were collected using EndNote, and abstracts
were categorized preliminarily, according to predeter-
mined inclusion and exclusion criteria (Table 1). Four
independent reviewers categorized all abstracts, and inclu-
sion was determined based on consensus from at least
two of four reviewers.
Secondary categorization
Full-text articles were sought for all citations that ini-
tially met inclusion criteria. Four reviewers categorized
each article independently according to four broad cat-
egories, initially described by Morris [16]; 1) barriers rele-
vant to the Health System Context, 2) barriers relevant to
the Patient Sociodemographic Context, 3) Patient Factors,


















Figure 1 Categorization of abstracts & articles.category were defined based on trends identified in a pre-
liminary literature review, and reviewers subcategorized
each article. Consensus by at least two reviewers deter-
mined assignment under a given theme.
Thematic analysis
Articles categorized under each theme were grouped to-
gether and reviewed for relevant data, common research
findings, and salient insight.
Results
Initial categorization
A flowchart of the categorization of articles is provided
as Figure 1. A total of 535 unique abstracts were collec-
ted. Based on numbers and perceived relevance, a de-
cision was made to exclude the 29 articles published
before 2000, with the assumption that any relevant in-
sight published earlier would be captured through cita-
tion in more recent studies. A further 405 abstracts were
discarded upon initial review as not meeting criteria. Of
those discarded, many related to psychosocial concerns
of patients already receiving radiation therapy, practice
patterns concerning dose and fractionation schedules,
and cost analyses of RT provision. A total of 130 abs-
tracts were thus included in the secondary thematic
categorization.
Secondary categorization
Full-text articles were found for all but 8 (6.1%) abs-
tracts, either online or in hard-copy. No further means
were undertaken to obtain the full-text of outstanding
articles. Upon review of full-text, a further 47 articles
were discarded as being irrelevant, most commonly as
not being Canadian or referring to comparisons of radia-
tion treatment techniques and fractionation schedules.
This left 75 articles for analysis.
These articles were subsequently categorized by theme






















Table 2 Categorization and themes of articles (n = 75)
Category n (%) Barrier theme n (%) Reference
Health System Context 52 (69.3%) Distance to Treatment Centre 23 (30.7%) [10,17-38]
Wait Times 22 (29.3%) [6-8,17,18,23,28,39-53]
Treatment Centre Characteristics 17 (22.7%) [18,33,39,41,43,46,47,54-63]
Patient Sociodemographic Context 30 (40.0%) Race/Ethnicity 1 (1.3%) [9]
Socioeconomic Status 8 (10.7%) [20,23,27,30,33,37,62,64]
Other 21 (28.0%) [6,10,25,28,31,36,39,41,43,46,51,61,65-72]
Patient Factors 30 (40.0%) Age 26 (34.7%) [6,8,11,12,20,27-33,35,38,50,51,66,71-78]
Cultural Beliefs 1 (1.3%) [9]
Beliefs re: Efficacy/ Burden of Treatment 1 (1.3%) [71]
Life Expectancy 2 (2.6%) [28,30]
Other 1 (1.3%) [25]
Provider Factors 25 (33.3%) Lack of Referral 12 (16.0%) [10,13,14,24,30,37,50,77-81]
Lack of Understanding/Awareness 16 (21.3%) [13,14,17,19,34,39,46,50,60,64,67,68,73,75,82,83]
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under multiple headings. In some articles, the theme was
not the overall focus of the investigation and might only
have been discussed briefly, but was still felt relevant by
investigators.
The most identified theme was age (n = 26, 34.7%),
under Patient Factors, followed by distance to a treat-
ment centre (n = 23, 30.7%), the characteristics of the
treatment centre (n = 17, 22.7%), and wait times for RT
(n = 22, 29.3%), which were all barriers in the Health
System Context. Provider Factors were also identified,
namely a lack of understanding or awareness (n = 16, 21.6%)
and a lack of referral (n = 12, 16.0%). Under the heading
of Patient Sociodemographic Context, socioeconomic sta-
tus was discussed in 8 articles (10.7%).
Thematic analysis
Health system context
Wait times were the most frequently identified theme
in the health system context. Studies investigated the
length of wait times [8,23,40,43,44,49,53] and whether
the length was actually a barrier to utilization [17,39,50].
The most recent wait time data found worsening wait
times in Nova Scotia for breast cancer patients in 2004
[49], improved wait times in BC between 2004 and 2008
[53], and unchanged wait times between 1995 and 2005
at an institution in Toronto [44]. Looking at head and
neck cancer patients in the Maritimes, Belyea et al. [40]
found that between 74% and 94% of patients were wait-
ing longer for RT between 2007 and 2009 than target
standards set by Cancer Care Ontario. Despite the va-
riability in wait times between jurisdictions and over
time, subjective interviews and survey data from 3 stu-
dies found wait times to be nonetheless be identified as
a barrier to RT utilization by either patients or providers[17,39,50]. Patients were potentially refusing the moda-
lity because of the wait, and providers were often not
making referrals due to a perception that treatment would
be delayed.
The impact of distance to treatment centres was in-
consistent. Three articles support distance as a barrier
[20,33,37], but only in certain scenarios. Danielson et al.
[20] found it to be a barrier only in older and lower in-
come patients and when coming from a larger commu-
nity. Johnston et al. [37] found that distance was no
longer a barrier once the patient had entered the RT sys-
tem. The influence of distance on utilization rates was
confounded by lower referral rates in remote locations,
such as the BC interior and rural Ontario [10,24,50].
No studies explicitly addressed whether lower referral
rates reflected patients’ reluctance to travel for RT or
the physicians’ lack of consideration of RT as a treatment
option.
Characteristics of RT treatment centres, including
their geographical distribution, were important in con-
sidering distance as a barrier to RT [21]. Rural counties
and those without facilities had lower rates for palliative
RT in Ontario [33,84] and Nova Scotia [30], and for
breast and lung cancers in BC [36]. Conversely, this bar-
rier was not seen in prostate cancer in BC [36]. If the
initial diagnosis was made in an academic hospital or
one with an affiliated cancer centre, or if a patient’s
referring physician resided in a county with a cancer
centre, the patient had a significantly greater likelihood
of receiving RT [19,27,33]. Tyldesley et al. [36] argued
that rural areas have fewer specialists with adequate
knowledge of the indications for RT, and Gray et al. [25]
highlighted a lack of patient support modalities. Notably,
patient outcomes were not different between the high-
volume and low-volume institutions [45].
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Themes elucidated in these categories were often inter-
related, and tended to cluster around age and socioeco-
nomic status. Referral rates were inversely related to age.
While the magnitude of difference varied, older patients
were found to be less likely to be referred for RT in a va-
riety of contexts, jurisdictions, and disease sites (Table 3).
In most instances, multivariate analyses demonstrated in-
creasing age and comorbidities to be independent predic-
tors of non-referral, and even non-treatment with respect
to RT. As noted by Tyldesley et al. [78], “relative decline
in the use of radiotherapy for palliative and adjuvant indi-
cations is more rapid than the decline in functional status
with age in the general population”.
The relationship between income and access to treat-
ment was discussed in eight articles, but the rela-
tionship was unclear. Those from lower income areas
generally had lower rates of consultation and utilization
[20,30,33,37,62]. However, this relationship was found to
be statistically insignificant on univariate analysis in an-
other study [27]. In yet another, it was noted that income
extremes had a much greater effect on rural populations
in California than on similar populations in Ontario [69].
In some of these studies, there was a confounding variable
of distance from treatment centre (often associated with
lower income) that was not always controlled for in the
analyses. Interestingly, lower income conferred a slight
benefit in Quebec, where there was found to be an asso-
ciation with shorter wait times [23].
Other patient-dependent barriers included education
level, associated with longer RT wait times [23], and life
expectancy, associated with lower rates of consultation
and treatment for palliation [30,37]. Patient refusal was
also noted as a barrier [9,71], though it was ill-defined in
the study by Puts et al. [71], as patients were not asked
for their reasons for refusing treatment. The authors did
note that it was most often older patients living alone, po-
tentially refusing for such reasons as a lack of physicianTable 3 Sites & provinces where older age related to





Colorectal cancer Ontario [77]
Endometrial British Columbia [12]
Nasopharynx Ontario [78]
Palliative Nova Scotia [30,37]
Ontario [27,33,78]
Prostate Ontario [51]
Small-cell lung British Columbia [11]recommendation or not perceiving a need. Chinese wo-
men in BC refused adjuvant RT after breast-conserving
surgery more than South Asian or Iranian women. This
was attributed to the desire expressed by Chinese women
“to be rid of their cancer” in a way they did not believe
possible with RT [9]. No such differences were found bet-
ween ethnic groups for surgery, chemotherapy, or hor-
mone therapy utilization. This single study suggests that
cultural beliefs, ethnicity, and poor understanding of the
nature of RT could be barriers to RT, though these factors
were not identified elsewhere in the Canadian literature.
Provider factors
The major themes identified under Provider Factors
were lack of referral and poor knowledge or awareness
about RT. These themes are integrally related and were
often the underlying issue identified in the discussion of
other barriers. Higher referral rates were associated with
having a university academic appointment, being a spe-
cialist in a cancer centre, performing a higher volume of
surgeries for cancers potentially requiring adjuvant RT,
being more knowledgeable about RT, or having formal
training in RT [13,14,19,30,82]. It was particularly note-
worthy to find that physicians lacking certification by
the Royal College of Physicians and Surgeons of Canada
had higher referral rates for neoadjuvant RT for rectal
cancers, being more likely to refer all patients rather
than only those with certain clinical indications [19].
In a retrospective chart review in Nova Scotia, Lavergne
et al. [30] found the difference between referral and
utilization rates varied greatly between certain disease
sites. The difference was high in Head and Neck cancers,
where there were often concerns about comorbidities,
and those referred were often not deemed eligible for
treatment. For those who had received previous RT,
referrals almost always led to RT utilization. A study in
British Columbia noted that “the referral system acts as
the initial gateway to the cancer system. The [British
Columbia Cancer Agency] can only provide appropriate
care to those who are referred” [24].
Low referral rates can be attributed in part to limited
RT-related knowledge of the referring physician. Self-
reported knowledge was poor in the majority of survey
respondents in three separate investigations [13,34,82].
Poor self-rated knowledge was also correlated with poor
actual knowledge in terms of indications for RT, quality
of life considerations, and potential treatment effective-
ness. A study in Nova Scotia found that patients referred
for palliative RT tended not to be referred a second time,
suggesting that providers were under a mistaken belief
that RT could only be used once [30]. Another issue for
referring physicians was not understanding the RT refer-
ral process, or not knowing who to contact to make a re-
ferral [13,34,85]. The understanding of patient preference
Gillan et al. Radiation Oncology 2012, 7:167 Page 5 of 8
http://www.ro-journal.com/content/7/1/167relating to RT was also considered. Tucker et al. [14]
reported that 51% of Canadian paediatric oncologists be-
lieved palliative RT was underutilized for reasons such as
family reluctance, distance, doubt about effect on quality
of life, and concerns regarding toxicity, but the authors
expressed concerns that some of these beliefs might be
misinformed. Tyldesley et al. [78] confirmed that “physi-
cians can be inaccurate in the judgment of patient prefer-
ence” (p479).
Only 16% of family physicians in Eastern Ontario [13]
and 62% of Canadian paediatric oncologists [14] repor-
ted having had any formal RT training. The scope of this
education ranged from a single lecture to a year-long
clinical rotation for the family physicians, and lasted a
median of 4 weeks in duration for the paediatric on-
cologists. Samant et al. [13] reported “lack of education
[amongst family physicians in Eastern Ontario]. . .. to be
a major barrier to radiotherapy” (p662). Indeed, 94% of
those with training made referrals, as opposed to 73% of
those without [14]. The majority of providers in various
contexts agreed that they might benefit from more infor-
mation about RT [13,34], with one study noting that
there would be a preference for small group sessions to
accomplish this [34]. Samant et al. [13] made the im-
portant point that educating family physicians might
have a high impact for few resources.
Discussion
In this review of Canadian literature, no single study
attempted to comprehensively identify or quantify all bar-
riers to access to treatment. The existence of similar but
differently-focused reviews and the variety of issues identi-
fied suggest the potential value of completing such a study
in future. While such factors as patient age, distance to
treatment centre, and wait times were prevalent and
expected, the role of the provider as a barrier to RT, and
the lack of information pertaining to patient fears and
misbeliefs are of particular interest, as they were unex-
pected findings in this review.
Patients must be referred in order to receive RT, and
low referral rates were frequently noted in the Canadian
literature, though rarely as the primary focus of an ar-
ticle. A lack of referral for RT was an underlying issue in
the discussion of a number of health systems factors,
such as distance to treatment and wait times. It also
appears that the referring physician may decide not to
refer due to beliefs that the patient would refuse or be
inconvenienced. A related issue was a lack of under-
standing of RT. The few studies that attempted to rate
the knowledge of referring physicians about RT found
that there was a general lack of formal training for those
who were in a position to refer for RT. This review
demonstrated that provider factors were not only bar-
riers unto themselves, but were also contributed to anumber of other health systems and patient factors
barriers.
Patient-related barriers included age, income, and edu-
cation level, and yet it is perhaps the least addressed bar-
rier, patient refusal, that is the most intriguing. Patient
fears and mistrust were prevalent in other jurisdictions,
but were discussed only tangentially in the Canadian lit-
erature on RT. African American populations in the
United States were found to be mistrustful of the field of
radiation medicine [86], and populations in Vietnam and
Pakistan held religious beliefs that led to refusal of RT
[87,88]. It would be important to discern whether such
fears and beliefs do exist amongst Canadians. In a theme
acknowledged in only a single Canadian study in this re-
view [9], but more frequently elsewhere [89,90], women
of one ethnic group were found to often refuse adjuvant
RT for breast cancer due to fears of efficacy and side
effects. The lack of further insight into Canadians’ per-
ceptions of radiation may reflect an important gap in the
literature deserving further study.
In some instances, the barriers identified in this review
were presented in the context of a proposed solution.
This tended to be on an institutional basis, and most
commonly concerned a dedicated palliative clinic, with
an accelerated diagnostic and planning process and a
centralized referral system [18,38,56,57]. Single solutions,
devised to overcome multiple identified barriers, were
proven to be effective initiatives. In other areas, such as
the lack of formal training for providers, potential solu-
tions were suggested but not implemented within the
scope of the article. In the majority of literature reviewed,
barriers were identified but authors stopped short of pro-
posing solutions. Future work should focus on prioritiz-
ing barriers, developing implementable solutions, and
performing cost/effort analyses to determine where the
greatest benefit might be achieved. Education, both of
patients and providers, is expected to play a significant
role in devising solutions.
There are a number of limitations to this work. While
the search strategy was repeatedly broadened and re-
fined to ensure comprehensiveness, it is possible that
some relevant articles were not collected here. Limiting
the scope of the review to recent Canadian literature
might also have led to the exclusion of important work,
though these restrictions were put in place to ensure ap-
plicability to the contemporary Canadian health care
context. Another potential limitation is that no state-
ment was made as to how prevalent an issue needed to
be in a given article to warrant inclusion as a barrier.
Some barriers were the primary focus of some studies
but only mentioned in passing in others. Given the lack
of a strong cutoff point, articles were included if it was
felt that a barrier was given enough attention to make a
statement about its importance. Despite these limitations,
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identified, as well as the most salient points about trends
in each.
Conclusion
This review of the Canadian literature identified a num-
ber of barriers to access to RT in four distinct areas:
health systems context, patient socio-demographic con-
text, patient factors, and provider factors. The most
often cited reasons for not receiving RT when indicated
were patient age distance to treatment centre, wait times,
and a lack of understanding about RT on the part of the
referring physician. The fact that provider factors were
often significant barriers and that patient fears and mis-
trust were not as prevalent as expected were themes that
emerged in this review that demand further attention. If
solutions can be devised that would allow patients to over-
come barriers to accessing RT, utilization of this treatment
modality would likely increase, thus meeting established
benchmarks and ensuring more effective use of RT for
cancer care for Canadians.
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